A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression
Status:
Terminated
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of Herceptin in patients with metastatic or
advanced gastric cancer with disease progression during platinum-based or
5-fluoropyrimidine-based chemotherapy. The anticipated time on study treatment is until
disease progression.